3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
24
Neoplasms
4
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Hodgkin Disease
2
Sleep Apnea, Obstructive
1
Recurrence
1
Prostate Adenocarcinoma
1
Premenopausal Breast Cancer
1
Polycystic Ovary Syndrome
1
Myeloproliferative Disorders
1
Metabolic Syndrome
1
Lymphoma, Mantle-Cell
1
Leukemia, Myeloid, Acute
1
Leiomyoma
1
Insulin Resistance
1
Glucose Intolerance
1
Breast Neoplasms
1
Interventions
pembrolizumab
1
exemestane
1
Leuprolide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Premenopausal Breast Cancer
×
Leuprolide
×
Clear all
NCT02990845
2023-02-22
PEER
National Taiwan University Hospital
Phase 1/2
Terminated
16 enrolled